Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23722)

• Formulation Name: Doxorubicin Hydrochloride 20mg/10ml liposomaldispersion
• Company: Baxter Healthcare Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Doxorubicin	(DMVP5YE)	Acute myelogenous leukaemia	2A41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonium sulfate	(E00490)	6097028	Buffering agent
Cholesterol	(E00092)	5997	Emollient; Emulsifying agent
Histidine	(E00106)	6274	Antioxidant; Buffering agent
Hydrochloric acid	(E00015)	313	Acidulant
N-(carbonyl-methoxypolyethylene glycol 2000)-1	(E00685)	86278269	Other agent
Saccharose	(E00091)	5988	Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Soybean lecithin	(E00637)	Not Available	Other agent